News
Sarepta Therapeutics shares were lower in premarket trading on Tuesday, as the drugmaker relented to a Food and Drug Administration request to halt shipments of a gene therapy. Sarepta shares (SRPT) ...
U.S. stock indexes inched their way to more records on Monday to kick off a week full of profit updates from big U.S.
U.S. stock indexes inched their way to more records Monday to kick off a week full of profit updates from big U.S. companies.
U.S. stock indexes inched their way to more records on Monday to kick off a week full of profit updates from big U.S.
U.S. stock indexes inched to more records to kick off a week full of profit updates from big U.S. companies. The S&P 500 rose ...
U.S. stock indexes inched their way to more records on Monday to kick off a week full of profit updates from big U.S. compan ...
Asian shares are mixed and U.S. futures have edged higher after U.S. stocks logged their third straight winning week.
Charles Schwab has expanded the list of securities available on its thinkorswim platform for overnight trading.
23h
InvestorsHub on MSNSarepta Shares Drop as FDA Suspends Gene Therapy Trials for Muscular DystrophyShares of Sarepta Therapeutics Inc (NASDAQ:SRPT) plunged 10% after the company disclosed that the U.S. Food and Drug ...
The restructuring enacted by Sarepta Therapeutics is expected to save up to $400 million in annual costs. Read why I'm ...
Stocks on Sky High. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is one of the top-performing companies on Thursday. Sarepta ...
On March 18, 2025, Sarepta announced that a patient that had been treated with Elevidys died after suffering acute liver failure. On this news, the price of Sarepta stock fell $27.81 per share, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results